Cargando…
Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting
Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting. Methods: A retrosp...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364442/ https://www.ncbi.nlm.nih.gov/pubmed/18476047 http://dx.doi.org/10.1155/S106474499500069X |
_version_ | 1782153955410706432 |
---|---|
author | Bardeguez, Arlene D. Denny, Thomas Palumbo, Paul Wesley, Yvonne Oleske, James Connor, Edward Weiss, Gerson |
author_facet | Bardeguez, Arlene D. Denny, Thomas Palumbo, Paul Wesley, Yvonne Oleske, James Connor, Edward Weiss, Gerson |
author_sort | Bardeguez, Arlene D. |
collection | PubMed |
description | Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting. Methods: A retrospective review was carried out of the prenatal HIV-1 counseling and testing program at University Hospital, Newark, NJ (1989-1990). Results: Sixty-seven percent (741/1,114) of the women offered HIV-1 counseling services accepted testing and 40 (40/741:5.3%) new cases were identified. Heterosexual contact was the primary exposure (17:52%) of these women, of whom 13 (73%) had negative syphilis serologies. Sixty-four percent were asymptomatic. The mean absolute CD4 lymphocyte count in seropositive women was 514 ± 305 cells/mm(3) . Severe immunosuppression was seen in 7/32 (22%) patients. Seventy-three percent (24/33) depended on public-assistance programs for their health-care services. Conclusions: A voluntary HIV-1 counseling and testing program is well accepted in the prenatal setting. It can provide early identification of asymptomatic seropositive women and infants at risk and lead to early intervention and therapy. |
format | Text |
id | pubmed-2364442 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1995 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-23644422008-05-12 Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting Bardeguez, Arlene D. Denny, Thomas Palumbo, Paul Wesley, Yvonne Oleske, James Connor, Edward Weiss, Gerson Infect Dis Obstet Gynecol Research Article Objective: The objectives of this study were to ascertain the acceptance rate of human immunodeficiency virus type 1 (HIV-1) testing in a high-prevalence area and to describe the sociodemographic and clinical characteristics of seropositive women diagnosed in the prenatal setting. Methods: A retrospective review was carried out of the prenatal HIV-1 counseling and testing program at University Hospital, Newark, NJ (1989-1990). Results: Sixty-seven percent (741/1,114) of the women offered HIV-1 counseling services accepted testing and 40 (40/741:5.3%) new cases were identified. Heterosexual contact was the primary exposure (17:52%) of these women, of whom 13 (73%) had negative syphilis serologies. Sixty-four percent were asymptomatic. The mean absolute CD4 lymphocyte count in seropositive women was 514 ± 305 cells/mm(3) . Severe immunosuppression was seen in 7/32 (22%) patients. Seventy-three percent (24/33) depended on public-assistance programs for their health-care services. Conclusions: A voluntary HIV-1 counseling and testing program is well accepted in the prenatal setting. It can provide early identification of asymptomatic seropositive women and infants at risk and lead to early intervention and therapy. Hindawi Publishing Corporation 1995 /pmc/articles/PMC2364442/ /pubmed/18476047 http://dx.doi.org/10.1155/S106474499500069X Text en Copyright © 1995 Hindawi Publishing Corporation. http://creativecommons.org/licenses/by/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Bardeguez, Arlene D. Denny, Thomas Palumbo, Paul Wesley, Yvonne Oleske, James Connor, Edward Weiss, Gerson Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting |
title | Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting |
title_full | Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting |
title_fullStr | Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting |
title_full_unstemmed | Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting |
title_short | Human Immunodeficiency Virus Type 1 Counseling and Testing Program in the Prenatal Setting |
title_sort | human immunodeficiency virus type 1 counseling and testing program in the prenatal setting |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364442/ https://www.ncbi.nlm.nih.gov/pubmed/18476047 http://dx.doi.org/10.1155/S106474499500069X |
work_keys_str_mv | AT bardeguezarlened humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting AT dennythomas humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting AT palumbopaul humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting AT wesleyyvonne humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting AT oleskejames humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting AT connoredward humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting AT weissgerson humanimmunodeficiencyvirustype1counselingandtestingprogramintheprenatalsetting |